Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?

被引:1
|
作者
Park, Jihye [1 ,2 ]
机构
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea
关键词
NECROSIS FACTOR THERAPY; CROHNS-DISEASE; RISK-FACTORS; SURGERY; VEDOLIZUMAB;
D O I
10.5217/ir.2021.00170
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1 / 2
页数:2
相关论文
共 50 条
  • [1] Perioperative Complications in Inflammatory Bowel Disease
    Beddy, David
    Dozois, Eric J.
    Pemberton, John H.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (07) : 1610 - 1619
  • [2] Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
    Poylin, Vitaliy Y.
    Serrato, Jose Cataneo
    Del Valle, Jonathan Pastrana
    Feuerstein, Joseph D.
    INTESTINAL RESEARCH, 2022, 20 (01) : 72 - 77
  • [3] Choosing the right biologic for complications of inflammatory bowel disease
    Rakowsky, Shana
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (03) : 235 - 249
  • [4] Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
    Jose Garcia, Maria
    Rivero, Montserrat
    Miranda-Bautista, Jose
    Baston-Rey, Iria
    Mesonero, Francisco
    Leo-Carnerero, Eduardo
    Casas-Deza, Diego
    Cagigas Fernandez, Carmen
    Martin-Cardona, Albert
    El Hajra, Ismael
    Hernandez-Aretxabaleta, Nerea
    Perez-Martinez, Isabel
    Fuentes-Valenzuela, Esteban
    Jimenez, Nuria
    Rubin de Celix, Cristina
    Gutierrez, Ana
    Suarez Ferrer, Cristina
    Maria Huguet, Jose
    Fernandez-Clotet, Agnes
    Gonzalez-Vivo, Maria
    Del Val, Blanca
    Castro-Poceiro, Jesus
    Melcarne, Luigi
    Duenas, Carmen
    Izquierdo, Marta
    Monfort, David
    Bouhmidi, Abdel
    Ramirez De la Piscina, Patricia
    Romero, Eva
    Molina, Gema
    Zorrilla, Jaime
    Calvino-Suarez, Cristina
    Sanchez, Eugenia
    Nunez, Andrea
    Sierra, Olivia
    Castro, Beatriz
    Zabana, Yamile
    Gonzalez-Partida, Irene
    De la Maza, Saioa
    Castano, Andres
    Najera-Munoz, Rodrigo
    Sanchez-Guillen, Luis
    Castro, Micaela Riat
    Luis Rueda, Jose
    Manuel Benitez, Jose
    Delgado-Guillena, Pedro
    Tardillo, Carlos
    Pena, Elena
    Frago-Larramona, Santiago
    Carmen Rodriguez-Grau, Maria
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [5] Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Melmed, Gil Y.
    Irving, Peter M.
    Casteele, Niels Vande
    Kozuch, Patricia L.
    Raffals, Laura E.
    Baidoo, Leonard
    Bressler, Brian
    Devlin, Shane M.
    Jones, Jennifer
    Kaplan, Gilaad G.
    Sparrow, Miles P.
    Velayos, Fernando S.
    Ullman, Thomas
    Siegel, Corey A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1655 - +
  • [6] Use of biologic agents in pediatric inflammatory bowel disease
    Rosh, Joel R.
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (05) : 646 - 650
  • [7] The use of biologic agents in pediatric inflammatory bowel disease
    Yang, Linda S.
    Alex, George
    Catto-Smith, Anthony G.
    CURRENT OPINION IN PEDIATRICS, 2012, 24 (05) : 609 - 614
  • [8] Should biologic agents be stopped before surgery for inflammatory bowel disease?
    Zaghiyan, Karen
    McGovern, Dermot
    Fleshner, Phillip
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (03) : 269 - 272
  • [9] Biologic Therapy in Inflammatory Bowel Disease
    Theede, Klaus
    Dahlerup, Jens Frederik
    Fallingborg, Jan
    Hvas, Christian Lodberg
    Kjeldsen, Jens
    Munck, Lars Kristian
    Nordgaard-Lassen, Inge
    DANISH MEDICAL JOURNAL, 2013, 60 (06):
  • [10] Q: Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?
    Moosvi, Zain
    Abadir, Alexander
    Duong, Jacqueline
    Nguyen, Douglas
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (06) : 343 - 346